Encompass Health Corporation vs OPTION CARE HEALTH, INC., two Medical Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Both companies grow with the migration of care away from acute hospitals, Encompass building rehabilitation hospitals, Option Care infusing therapies at home, and the market prices them within a tenth of a turn, 16.9 and 17 times earnings. From there the shapes split: Encompass earns the deeper margins, a 10% net against 3.6%, and the higher return on equity, 18.4% against 15.3%, but its expansion swallows cash, a negative 7.2% free-cash figure against Option Care's positive 6.2%. Debt is moderate at both. Identical multiples on opposite cash postures make this pair a clean question: pay for earnings being reinvested in buildings, or for earnings arriving as cash. The prices refuse to choose, so the buyer must.
Comparison updated 2026-07-10.
| Metric | EHC | OPCH |
|---|---|---|
| Price | $101.30 | $21.76 |
| Market cap | $10.2B | $3.4B |
| Sector | Medical Care | Medical Care |
| Stage | Mature | Mature |
| Implied growth (priced in) | +8.8% | -4.3% |
| P/E | 16.9 | 17.0 |
| P/B | 3.08 | 2.55 |
| P/S | 1.68 | 0.61 |
| EV/EBITDA | 37.7 | 11.1 |
| Revenue growth | +10.1% | +9.4% |
| Gross margin | — | 19.4% |
| Operating margin | — | 5.4% |
| Net margin | 10.0% | 3.6% |
| Return on equity | 18.4% | 15.3% |
| Return on assets | 8.3% | 6.1% |
| Return on invested capital | — | 9.8% |
| FCF yield | -7.2% | 6.2% |
| Dividend yield | 0.7% | — |
| Debt / equity | 0.78 | 0.86 |
| Current ratio | 1.17 | 1.64 |
| Altman Z (solvency) | 2.40 | 3.31 |
| Piotroski F (quality) | 5 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.